India's Largest Database on New Projects
Lupin signs agreement with Abbott Labs, Laboratoires Fournier
27 April 2011: Lupin and its subsidiaries have signed a licence agreement with Abbott Laboratories and Laboratoires Fournier SA for eight patents on cholesterol-lowering drug Fenofibrate.
The agreement between the two parties also covered continuations, extensions, re-isues, re-examinations and so on. The agreement essentially “erases the patent uncertainty” on Lupin's products.
Lupin had, in 2009, bought Antara, a brand of Fenofibrate from Oscient Pharmaceuticals under the procedures of the US Bankruptcy Court, at about Rs 185 crore for the product and related assets and inventory. Fenofibrate was developed by Groupe Fournier SA and acquired in 2005 by Solvay Pharmaceutical. In late 2009, Solvay's pharma business was bought over by Abbott.
Source: Hindu Business Line